1. Home
  2. VINP vs PHAR Comparison

VINP vs PHAR Comparison

Compare VINP & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vinci Partners Investments Ltd.

VINP

Vinci Partners Investments Ltd.

SELL

Current Price

$9.26

Market Cap

638.8M

Sector

Finance

ML Signal

SELL

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$10.16

Market Cap

793.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VINP
PHAR
Founded
2009
1988
Country
Brazil
Netherlands
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
638.8M
793.4M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
VINP
PHAR
Price
$9.26
$10.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$14.00
★ $38.33
AVG Volume (30 Days)
★ 40.8K
33.8K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
★ 5.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.07
$10.04
Revenue Next Year
$12.74
$2.51
P/E Ratio
★ $24.41
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$9.13
$9.62
52 Week High
$13.61
$21.34

Technical Indicators

Market Signals
Indicator
VINP
PHAR
Relative Strength Index (RSI) 42.97 38.04
Support Level N/A $9.62
Resistance Level $10.17 $11.60
Average True Range (ATR) 0.26 0.47
MACD -0.00 -0.03
Stochastic Oscillator 14.94 9.45

Price Performance

Historical Comparison
VINP
PHAR

About VINP Vinci Partners Investments Ltd.

Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: